Incredible Buzz Hosts '2024 NutraCos Glow Night'... Accelerating Beauty Market Expansion

Im Sin-yeong, CEO of Incredible Buzz, is introducing the company at the '2024 NutraCos Glow Night' event. Photo by Incredible Buzz

Incredible Buzz announced on the 13th that it successfully held the '2024 NUTRAKOS GLOWNIGHT' event in Cheongdam-dong, Seoul.

This event was organized to promote NUTRAKOS products applying the optimal 6-amino acid blend formula 6AA and to emphasize competitiveness in the beauty market. The event was graced by key executives including CEO Shin Young Lim of Incredible Buzz, Tiziano Cameronli, CEO of PD (Professional Dietetics), and Paulo Luca Maria Zorgetti, founder of PD. Additionally, Korean and Chinese beauty influencers, open market MDs and sellers, and industry insiders joined to further energize the event.

At the event, Incredible Buzz introduced the NUTRAKOS Daily Amino Shot, currently offered domestically, and shared sales achievements. This product applies a patented amino acid formula from the US, Europe, and Korea, enabling simultaneous improvement of skin elasticity and moisture. Since its domestic launch in 2020, it has recorded total sales of 6 million units.

Also, the new products scheduled for release in 2025, ▲NUTRAKOS Active Accelerator Shot ▲Sunecos Performa/1200, were unveiled, attracting significant attention from industry stakeholders. The NUTRAKOS Active Accelerator Shot is a decaffeinated energy booster combining 10 amino acids (10AA) and SMC (chromosome structure maintenance component). Sunecos Performa/1200 is an injectable combining 6 amino acids and hyaluronic acid, offering excellent skin recovery and regeneration effects.

CEO Shin Young Lim of Incredible Buzz stated, “NUTRAKOS is a proprietary amino acid blend product developed through 25 years of clinical research by PD, boasting high safety and outstanding efficacy. Leading with NUTRAKOS, we will enhance brand awareness in the domestic beauty market and accelerate expansion into overseas markets including the United States.”

Meanwhile, on the 11th, Incredible Buzz signed a strategic business agreement (MOU) with Italy’s innovative pharmaceutical and bio research institute PD, securing exclusive rights for clinical trials and sales for PD products’ registration with the U.S. Food and Drug Administration (FDA), thereby officially launching its U.S. market entry.

This content was produced with the assistance of AI translation services.